Bone Marrow’s Role in Autoimmune Disease: A New Target Emerges
A pivotal study in Science Translational Medicine reveals a novel mechanism in neuromyelitis optica spectrum disorder (NMOSD), an autoimmune condition affecting the central nervous system. Researchers discovered that aberrant granulopoiesis—the process of neutrophil production—within the bone marrow generates a specific population of neutrophils that subsequently promote pathogenic B cell activity. This finding directly links dysregulated bone marrow hematopoiesis to the autoimmune attack characteristic of NMOSD, identifying the bone marrow niche as a previously underappreciated contributor to disease pathology beyond its role in standard blood cell production.
Study Significance: For hematologists and immunologists, this research expands the clinical relevance of bone marrow function beyond classical hematopoiesis and into the realm of neuroimmunology. It suggests that therapeutic strategies targeting specific bone marrow-derived immune cell populations could offer a new avenue for treating antibody-mediated autoimmune diseases. This insight may influence future drug development to modulate aberrant granulopoiesis as a method to control harmful B cell responses.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
